FGF21 is a hormone-like cytokine known to play key roles in glucose and lipid metabolism and it is currently being pursued as a therapeutic drug for obesity and T2-diabetes [50]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.